Hepatitis E Diagnostic Test MarketReport Analysis, Share, Revenue, Growth Rate With Forecast Overview

SDKI Inc. published a new report on the Global Hepatitis E Diagnostic Test Market-Forecast 2022-2030. This study includes the statistical and analytical approaches needed to grow the hepatitis E diagnostic test market. The key industry insights provided in the report provide readers with better ideas about market overviews regarding existing market scenarios. In addition, the report contains a detailed discussion of current and future market trends related to market growth.

Report sample URL
https://www.sdki.jp/sample-request-110305

The hepatitis E diagnostic test market is estimated to grow from a market value of US $ 54.60 million in 2022 to US $ 74.30 million by 2030, with a CAGR of 4.50% during the 2022-2030 forecast period. It is expected.

Hepatitis E virus mainly affects the liver in the world It is the main cause of acute viral hepatitis. Hepatitis E virus is considered a travel-related infection. The diagnosis of HEV is based on the detection of viral RNA in serum or feces. There is no special treatment for hepatitis E. Analysis of HEV performed on RNA in biological specimens such as liver biopsy, stool, and serum is used for diagnosis. In addition, national governments and health authorities are making various efforts to make diagnostic tests available in each country. The World Health Organization is focused on making vaccines and diagnostic tests available to reduce the global burden of illness.

In addition, key players are focusing on strategies such as product launches, innovations and M & A to maintain themselves in fierce competition. In addition, market growth is due to the rising prevalence of hepatitis E and the government's initiative in recognizing the diagnosis of hepatitis E. According to the World Health Organization in July 2020, WHO estimated that there are an estimated 20 million HEV infections worldwide each year, leading to 3.3 million symptomatic cases of hepatitis E. As a result, the need for hepatitis E diagnostic tests will increase, driving the growth of the hepatitis E diagnostic test market during the 2022-2030 forecast period. However, the high cost of diagnostic procedures and inadequate reimbursement policies can hinder the growth of the global hepatitis E diagnostic test market.

Global market growth can be attributed to various significant advances in the healthcare industry to promote health through the development of three basic parameters: detection, prevention, and treatment. These parameters are needed to measure health, quality of life, and the overall health system. In addition, rising medical costs are driving market growth. According to Organization for Economic Co-operation and Development (OECD) statistics, Japan's total per capita health care costs (government, compulsory health insurance, voluntary health insurance) increased from US $ 4297.13 in 2016 to US $ 4823 in 2019. Similarly, in the United States, it increased from $ 9880.16 to $ 11072 in 2019. Germany has witnessed an increase from $ 5668 to $ 6646, and the United Kingdom has observed growth from $ 3990 to $ 4653.05 during the above period. Globally, healthcare costs are projected to grow at a CAGR of approximately 5% between 2020 and 2024.

Sample URL of the report
https://www.sdki.jp/sample-request-110305

Advances in the healthcare sector are estimated to provide lucrative business opportunities for key players to take advantage of these opportunities in the coming years. In addition, there are several initiatives taken by healthcare professionals and government agencies to overcome some challenges (unreachable and affordable medical services, lack of investment in health care, trained doctors and nurses, etc.). It is expected to boost market growth during the forecast period.

Hepatitis E Diagnostic Test Market Segment

The hepatitis E diagnostic test market is by test type (HEV IgM ELISA test kit, HEV IgG ELISA test kit, RT-PCR test kit, etc.), by end user (hospital, diagnostic laboratory, research center, point of care), And divided by region. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

Regional overview of the hepatitis E diagnostic test market

The hepatitis E diagnostic test market is further subdivided based on the region, and the market growth of each country is evaluated. These include North America (US, Canada, and other North America), Europe (Germany, France, Italy, Spain, UK, and other Europe), Asia Pacific (China, Japan, India, Australia, Singapore, and others). Asia Pacific) and other regions.

The Asia Pacific region is the world's leading region in terms of market share. This is due to the increasing incidence of hepatitis E in some countries in the region, including Nepal, Vietnam, Pakistan, Bangladesh, Burma, Kazakhstan, Thailand and Bhutan. Domination of the region has also been witnessed due to proper hygiene that can cause hepatitis E and lack of access to safe drinking water. In addition, the Asia Pacific hepatitis E diagnostic test market is expected to show the highest growth rate / CAGR during the forecast period (2022-2030).

A major key player in the hepatitis E diagnostic test market

Key players in the hepatitis E diagnostic test market include Altona Diagnostics GmbH, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., Biokit SA, Dia.Pro --Diagnostic Bioprobes srl, F. Hoffmann-La Roche Ltd., Fast. -track diagnostics Ltd., Fortress Diagnostics Limited, Mikrogen GmBH, MP Biomedicals, LLC., Primerdesign Ltd. and more. The study includes in-depth competitive analysis, corporate profiles, recent developments, and key market strategies for these major companies in the hepatitis E diagnostic test market.

Details of the survey report
https://www.sdki.jp/press-details/global-hepatitis-e-diagnostic-test-market-market/202

Contact Us

Hina Miyazu
15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

This release was published on openPR.